16135465

Source:http://linkedlifedata.com/resource/pubmed/id/16135465

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16135465	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0153467	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0205065	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0079083	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C1176309	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0034897	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0920321	lld:lifeskim
pubmed-article:16135465	lifeskim:mentions	umls-concept:C0205225	lld:lifeskim
pubmed-article:16135465	pubmed:issue	25	lld:pubmed
pubmed-article:16135465	pubmed:dateCreated	2005-9-1	lld:pubmed
pubmed-article:16135465	pubmed:abstractText	To determine the maximum-tolerated dose, pharmacodynamics, and safety of the combination of bortezomib and carboplatin in recurrent ovarian cancer.	lld:pubmed
pubmed-article:16135465	pubmed:grant	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:language	eng	lld:pubmed
pubmed-article:16135465	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16135465	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16135465	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16135465	pubmed:month	Sep	lld:pubmed
pubmed-article:16135465	pubmed:issn	0732-183X	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:DupontJJ	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:SpriggsD RDR	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:SabbatiniPP	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:AghajanianCC	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:RaizerJ JJJ	lld:pubmed
pubmed-article:16135465	pubmed:author	pubmed-author:DizonD SDS	lld:pubmed
pubmed-article:16135465	pubmed:issnType	Print	lld:pubmed
pubmed-article:16135465	pubmed:day	1	lld:pubmed
pubmed-article:16135465	pubmed:volume	23	lld:pubmed
pubmed-article:16135465	pubmed:owner	NLM	lld:pubmed
pubmed-article:16135465	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16135465	pubmed:pagination	5943-9	lld:pubmed
pubmed-article:16135465	pubmed:dateRevised	2007-11-14	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:meshHeading	pubmed-meshheading:16135465...	lld:pubmed
pubmed-article:16135465	pubmed:year	2005	lld:pubmed
pubmed-article:16135465	pubmed:articleTitle	Phase I trial of bortezomib and carboplatin in recurrent ovarian or primary peritoneal cancer.	lld:pubmed
pubmed-article:16135465	pubmed:affiliation	Developmental Chemotherapy Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA. aghajanc@mskcc.org	lld:pubmed
pubmed-article:16135465	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:16135465	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:16135465	pubmed:publicationType	Research Support, U.S. Gov't, P.H.S.	lld:pubmed
pubmed-article:16135465	pubmed:publicationType	Clinical Trial, Phase I	lld:pubmed
pubmed-article:16135465	pubmed:publicationType	Research Support, N.I.H., Extramural	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16135465	lld:pubmed